Supplementary MaterialsSupplementary information 41541_2018_96_MOESM1_ESM. lethal challenge with SFTSV was conferred in

Supplementary MaterialsSupplementary information 41541_2018_96_MOESM1_ESM. lethal challenge with SFTSV was conferred in previous and youthful immunocompromised mice regardless of any kind of pre-existing vector-specific immunity. Collectively, these outcomes claim that a rVSV vector expressing SFTSV glycoproteins is normally a promising applicant vaccine against two rising phleboviruses connected with serious human diseases. Launch Serious fever with thrombocytopenia… Continue reading Supplementary MaterialsSupplementary information 41541_2018_96_MOESM1_ESM. lethal challenge with SFTSV was conferred in